Researchers at Henry Ford Hospital have shown that skin transplant surgical operation is harmless and effectual for treating vitiligo, a skin disorder.
In their research, Henry Ford scientists followed 23 patients for six months after surgical operation and discovered that the treated region recovered on average 52% of its natural skin color.
In 8 patients suffering from a specific type of skin disease, the treated part regained on average 74% of its natural complexion.
The surgical procedure involves using skin cells taken from normally-pigmented areas of the body and transferring them to the damaged area of skin. It is carried out under local anesthesia.
Iltefat Hamzavi, M. D. a senior staff physician in Henry Ford''s Department of Dermatology and the study''s senior author and principal investigator, said, "This surgery offers hope to vitiligo patients."
"The results achieved in our study were of obvious significance to our patients," Hamzavi added.
The results of the research have been presented at the 68th annual American Academy of Dermatology conference in Miami.
While the early outcomes are prelim and the process is still investigational, Dr. Hamzavi said Henry Ford hopes to provide the surgical process as part of its treatment set this fall.
He says for some patients the surgery is more effectual than standard cures including light therapy and local medicines. (With Input from Agencies)
.








